Best Practices for an Effective Change Management System

Best Practices for an Effective Change Management System A mature Change Management System goes beyond regulatory compliance. It promotes continuous improvement while ensuring product quality, patient safety, and data integrity are maintained. The following best practices are widely adopted by leading pharmaceutical manufacturers. Establish a clear and comprehensive Change Control SOP. Apply Quality Risk Management … Read more

Change Control Workflow in Pharma

Complete Change Control Workflow in Pharmaceutical Industry An effective Change Management System follows a structured workflow that ensures every proposed modification is scientifically evaluated before implementation. Although individual pharmaceutical companies may customize their procedures, the fundamental workflow remains largely consistent across the industry. Step 1: Change Request Initiation The process begins when a need for … Read more

Change Management System In Pharmaceutical Industry

Change Management System in Pharmaceutical Industry: Complete Guide (2026) Change Management System in Pharmaceutical Industry: Complete Guide (2026) The pharmaceutical industry operates in one of the most highly regulated environments in the world. Every modification made to a manufacturing process, facility, equipment, computer system, analytical method, supplier, packaging material, or documentation has the potential to … Read more

HANDLING OF ALTERNATE VENDOR DEVELOPMENT (AVD) PROJECTS:

Alternate Vendor development for existing material shall be initiated through the Change control procedure. Supply chain / purchase team on its own or on the recommendation of Technology Transfer team / R&D / Production shall identify the vendor for existing material. Supply Chaim (SCM) / purchase Team shall initiate queries with the prospective vendors for … Read more

UNDERSTANDING OF SUPAC GUIDELINES (SCALE UP AND POST APPROVAL CHANGES):

This guidance provides recommendations to sponsors of new drug applications (NDA’s), abbreviated new drug applications (ANDA’s), and abbreviated antibiotic applications (AADA’s) who intend, during the post approval period, to change: SU: Scale-up during original dossier assessment. Note that this is not SU during development. Consider changes made after the Biobatch   PAC: Post-PQ/post-approval, i.e. Variations. … Read more

BASIC UNDERSTANDING OF QUALIFICATION, CALIBRATION AND PREVENTIVE MAINTENANCE:

QUALIFICATION: Qualification is the planning, carrying out and recording of tests on equipment and systems, which form part of the validated process, to demonstrate that it will perform as intended. All manufacturing equipment, laboratory instrument and supporting utilities shall be considered for qualification. After successful completion of qualification exercise, the Equipment / instrument / Utilities … Read more

BASIC UNDERSTANDING OF AREA AND ROOM CONDITIONS:

The premises used for warehousing, manufacturing, processing, storage, packaging labeling and testing purposes shall be; WAREHOUSING AREA: PRODUCTION AREA: ANCILLARY AREAS: QUALITY CONTROL AREA: REFERENCE: 1. Schedule M 2. 21 CFR art 210 & 211 3. WHO Technical Report Series 908